In general, the data in tumor-bearing mice provided further evidence that alizarin combined with Gem therapy inhibited tumor development by reducing NF-κB activity and was superior to alizarin or Gem alone, indicating a synergistic antitumor effect. The gene discussed is NFKB1; the disease is neoplasm.